OpenLoop Blog Search Blog

Content to power your healthcare delivery.

Your go-to resource for telehealth articles, trends and industry insights geared towards digital health companies and providers.

3D rendering of a peptide molecular structure beside a clear glass vial, illuminated in pink tones, representing Epithalon peptide compounding for healthcare businesses.
Peptides + Build & Scale

How to offer Epithalon at your business

Learn how to add Epithalon to your business under HHS's interim 503A compounding policy, from pharmacy sourcing and clinical protocols to state requirements.

By: OpenLoop Health November 20, 2026 • 9 min read

Glass peptide vial beside a digital healthcare dashboard with pink molecular graphics, representing MOTS-c peptide program infrastructure, pharmacy coordination, and compliance.
Peptides + Build & Scale

How to offer MOTS-c at your business

Learn how to offer MOTS-c to your business under HHS's interim 503A compounding policy, from pharmacy sourcing and clinical protocols to state compliance.

By: OpenLoop Health November 17, 2026 • 9 min read

3D illustration representing a GHK-Cu peptide vial beside a molecular structure and virtual care dashboard, representing the seven steps to offering GHK-Cu at a business.

How to offer GHK-Cu at your business

Learn how to offer GHK-Cu at your business compliantly, including its current FDA compounding status, route restrictions, pharmacy sourcing, and state rules.

By: OpenLoop Health November 16, 2026 • 8 min read

Glass peptide vial representing TB-500 surrounded by a translucent pink DNA double helix, illustrating peptide-based wellness services and TB-500 compounding for businesses.

How to offer TB-500 at your business

Learn how to add TB-500 to your business under HHS's interim 503A compounding policy, from pharmacy sourcing and clinical protocols to state compliance.

By: OpenLoop Health November 12, 2026 • 8 min read

Glass peptide vial representing BPC-157 beside a checklist and shield icon, illustrating 503A compounding requirements, pharmacy sourcing, and regulatory compliance for businesses.
Peptides + Build & Scale

How to offer BPC-157 to your business

Learn how to offer BPC-157 to your business under HHS's interim 503A compounding policy, from pharmacy sourcing and clinical protocols to state compliance.

By: OpenLoop Health November 10, 2026 • 8 min read

Stay ahead of digital health news

Our LinkedIn newsletter brings you a monthly snapshot packed with news, trends, policy shifts, and market signals: no inbox clutter, just one notification when it's live.

Subscribe